Search for: "SANOFI-SYNTHELABO"
Results 41 - 59
of 59
Sort by Relevance
|
Sort by Date
15 Dec 2008, 5:34 am
Sanofi-Synthelabo v. [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
21 Nov 2008, 11:36 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Plavix (Clopidogrel) – Canada: Supreme Court upholds selection patents: Apotex v Sanofi-Synthelabo Canada et al (Pharmacapsules @… [read post]
14 Nov 2008, 2:08 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Plavix (Clopidogrel) - Canada: Selection patents upheld by Supreme Court: Apotex v Sanofi-Synthelabo Canada (Jeremy de Beer) (ipblog.ca)… [read post]
7 Nov 2008, 8:35 am
Sanofi-Synthelabo Canada Inc. [read post]
7 Nov 2008, 4:11 am
In a 7-0 judgment on 6 Nov 08, the Canadien Supreme Court rejected a request from Apotex Inc. to invalidate Sanofi's patent for an anti-coagulant drug (Plavix) used to combat cardiovascular degeneration.Coverage by Kirk Makin in the Globe and Mail did NOT get to the heart of this court battle involving patenting of racemates vs. patenting of enantiomers:Judge Rothstein said that in case of Sanofi's anti-coagulant drug - marketed under the name, Plavix - the company showed… [read post]
7 Nov 2008, 3:42 am
Sandoz, Inc (Patent Docs) (PATracer) Boniva (Ibandronic acid) – US: Hoffman La Roche files third patent infringement lawsuit against Orchid over generic Boniva (GenericsWeb) Carbatrol (Carbamazepine) – US: Federal Judge grants summary judgment of noninfringement to Corepharma in Carbatrol patent dispute with Shire Laboratories (Law360) Effexor (Venlafaxine) – US: Wyeth settles with fourth drug company, Anchen Pharmaceuticals, over generic Effexor (Law360) Fentora… [read post]
27 Apr 2008, 9:57 pm
In March 2002, Sanofi-Synthelabo and Bristol-Myers Squibb sued Apotex for infringing the Orange Book-listed patent, U.S. [read post]
1 Jan 2008, 6:49 pm
Seagate – Petition from In re Seagate Bilski – Patent-Eligibility under § 101 Sanofi-Synthelabo – The Plavix Case Sang Su Lee II – Post-KSR Motivation Ferguson – Method of Marketing a Product Barnett – Internet-driven Method Hal Wegner’s list focuses on utility patent litigation. [read post]
1 Nov 2007, 8:20 am
The studies were carried out by Pharmaceutical Products Development (PPD) on behalf of Aventis, prior to its merger with Sanofi-Synthelabo. [read post]
2 Jul 2007, 2:51 pm
Perrigo Plavix: Sanofi-Synthelabo et al. v. [read post]
25 Jun 2007, 2:10 am
DISTRICT COURTSOUTHERN DISTRICT OF NEW YORKIntellectual Property
Sale of Generic Version of Plavix Blocked; Infringed Patent Not Proved Invalid or Unenforceable
Sanofi-Synthelabo v. [read post]
19 Jun 2007, 9:45 pm
Sanofi and BMS filed the action in March of 2002, contending that... [read post]
19 Jun 2007, 12:08 pm
Sanofi-Synthelabo v. [read post]
19 Jun 2007, 8:21 am
Sanofi-Synthelabo et al. v. [read post]
11 Feb 2007, 6:51 am
Atrix Laboratories, Inc. and Sanofi-Synthelabo Inc. [read post]
2 Nov 2006, 9:50 pm
District Court for the Southern District of New York granted a preliminary injunction to Sanofi-Synthelabo and Bristol-Myers Squibb in their patent infringement case against Apotex. [read post]
31 Aug 2006, 6:15 pm
Stein in Manhattan issued an injunction blocking the sale of generic Plavix ® (clopidogrel bisulfate) after a two-day hearing (Sanofi-Synthelabo v. [read post]
15 Aug 2006, 6:45 am
This is the court hearing the patent infringement suit, Sanofi-Synthelabo v. [read post]
